randox health london ltd
randox health london ltd Company Information
Company Number
09102173
Next Accounts
Mar 2025
Shareholders
ran dox holdings limited
Group Structure
View All
Industry
Other business support service activities n.e.c.
Registered Address
143-149 great portland street, marylebone, london, W1W 6QN
Website
www.randoxhealthlondon.comrandox health london ltd Estimated Valuation
Pomanda estimates the enterprise value of RANDOX HEALTH LONDON LTD at £14m based on a Turnover of £21.6m and 0.65x industry multiple (adjusted for size and gross margin).
randox health london ltd Estimated Valuation
Pomanda estimates the enterprise value of RANDOX HEALTH LONDON LTD at £0 based on an EBITDA of £-36.2m and a 4.73x industry multiple (adjusted for size and gross margin).
randox health london ltd Estimated Valuation
Pomanda estimates the enterprise value of RANDOX HEALTH LONDON LTD at £205.5m based on Net Assets of £96.4m and 2.13x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Randox Health London Ltd Overview
Randox Health London Ltd is a live company located in london, W1W 6QN with a Companies House number of 09102173. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in June 2014, it's largest shareholder is ran dox holdings limited with a 100% stake. Randox Health London Ltd is a established, large sized company, Pomanda has estimated its turnover at £21.6m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Randox Health London Ltd Health Check
Pomanda's financial health check has awarded Randox Health London Ltd a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs
5 Strong
1 Regular
4 Weak
Size
annual sales of £21.6m, make it larger than the average company (£3.7m)
£21.6m - Randox Health London Ltd
£3.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 329%, show it is growing at a faster rate (4.7%)
329% - Randox Health London Ltd
4.7% - Industry AVG
Production
with a gross margin of 21.1%, this company has a higher cost of product (37.9%)
21.1% - Randox Health London Ltd
37.9% - Industry AVG
Profitability
an operating margin of -186.9% make it less profitable than the average company (6.2%)
-186.9% - Randox Health London Ltd
6.2% - Industry AVG
Employees
with 327 employees, this is above the industry average (24)
327 - Randox Health London Ltd
24 - Industry AVG
Pay Structure
on an average salary of £48.3k, the company has an equivalent pay structure (£48.3k)
- Randox Health London Ltd
£48.3k - Industry AVG
Efficiency
resulting in sales per employee of £66.1k, this is less efficient (£154.2k)
£66.1k - Randox Health London Ltd
£154.2k - Industry AVG
Debtor Days
it gets paid by customers after 4 days, this is earlier than average (41 days)
4 days - Randox Health London Ltd
41 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Randox Health London Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Randox Health London Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 2 weeks, this is less cash available to meet short term requirements (24 weeks)
2 weeks - Randox Health London Ltd
24 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 7.8%, this is a lower level of debt than the average (61.7%)
7.8% - Randox Health London Ltd
61.7% - Industry AVG
RANDOX HEALTH LONDON LTD financials
Randox Health London Ltd's latest turnover from June 2023 is £21.6 million and the company has net assets of £96.4 million. According to their latest financial statements, Randox Health London Ltd has 327 employees and maintains cash reserves of £380.5 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Dec 2018 | Dec 2017 | May 2017 | May 2016 | May 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | 21,605,128 | 342,291,639 | 31,318,555 | 274,495 | 174,162 | 65,321 | 112,020 | 62,674 | |
| Other Income Or Grants | |||||||||
| Cost Of Sales | 17,046,845 | 167,520,245 | 10,975,248 | 414,729 | 312,247 | 115,194 | 38,107 | 22,238 | |
| Gross Profit | 4,558,283 | 174,771,394 | 20,343,307 | -140,234 | -138,085 | -49,873 | 73,913 | 40,436 | |
| Admin Expenses | 44,944,816 | 30,432,789 | 822,205 | 1,260,701 | 871,767 | 290,921 | 515,533 | 521,854 | |
| Operating Profit | -40,386,533 | 144,338,605 | 19,521,102 | -1,400,935 | -1,009,852 | -340,794 | -441,620 | -481,418 | |
| Interest Payable | 226,236 | 4,178,810 | 646,894 | 20,182 | 3,832 | ||||
| Interest Receivable | |||||||||
| Pre-Tax Profit | -40,612,769 | 140,159,795 | 18,874,208 | -1,421,117 | -1,013,684 | -340,794 | -441,620 | -481,418 | |
| Tax | 10,071,764 | -24,849,860 | -3,640,671 | 50,744 | |||||
| Profit After Tax | -30,541,005 | 115,309,935 | 15,233,537 | -1,370,373 | -1,013,684 | -340,794 | -441,620 | -481,418 | |
| Dividends Paid | |||||||||
| Retained Profit | -30,541,005 | 115,309,935 | 15,233,537 | -1,370,373 | -1,013,684 | -340,794 | -441,620 | -481,418 | |
| Employee Costs | 397,692 | 372,103 | 81,137 | 136,847 | 167,055 | ||||
| Number Of Employees | 327 | 530 | 10 | 10 | 13 | 4 | 3 | 4 | |
| EBITDA* | -36,169,151 | 147,318,569 | 19,677,700 | -1,159,905 | -846,221 | -333,217 | -437,107 | -479,635 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Dec 2018 | Dec 2017 | May 2017 | May 2016 | May 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 7,035,239 | 8,918,377 | 227,003 | 383,601 | 624,619 | 720,595 | 16,683 | 19,609 | |
| Intangible Assets | |||||||||
| Investments & Other | |||||||||
| Debtors (Due After 1 year) | |||||||||
| Total Fixed Assets | 7,035,239 | 8,918,377 | 227,003 | 383,601 | 624,619 | 720,595 | 16,683 | 19,609 | |
| Stock & work in progress | |||||||||
| Trade Debtors | 261,983 | 518,240 | 384,325 | 26,648 | 28,092 | 29,872 | 39,720 | 26,505 | |
| Group Debtors | 86,322,064 | 171,818,046 | 13,143,498 | 115,441 | 420 | 420 | 34,738 | 7,352 | |
| Misc Debtors | 10,379,062 | 90,412 | 81,749 | 135,329 | 62,907 | 34,218 | 95,333 | 67,215 | 1,000 |
| Cash | 380,489 | 428,668 | 7,325,397 | 211,055 | 2,043 | 4,860 | 4,834 | 21,316 | |
| misc current assets | 83,912 | 17,071 | |||||||
| total current assets | 97,427,510 | 172,872,437 | 20,934,969 | 488,473 | 93,462 | 69,370 | 174,625 | 122,388 | 1,000 |
| total assets | 104,462,749 | 181,790,814 | 21,161,972 | 872,074 | 718,081 | 789,965 | 191,308 | 141,997 | 1,000 |
| Bank overdraft | 1,012 | 1,974 | 39 | 114 | 2,356 | 72 | 384 | 630 | |
| Bank loan | |||||||||
| Trade Creditors | 372,443 | 104,341 | 68,862 | 117,874 | 137,454 | 101,577 | |||
| Group/Directors Accounts | 6,197,079 | 34,838,550 | 5,487,300 | 4,357,118 | 2,877,351 | 1,888,233 | 941,343 | 511,138 | |
| other short term finances | |||||||||
| hp & lease commitments | |||||||||
| other current liabilities | 1,909,080 | 20,053,707 | 3,715,542 | 57,390 | 46,028 | 46,618 | 34,165 | 9,070 | |
| total current liabilities | 8,107,171 | 54,894,231 | 9,575,324 | 4,518,963 | 2,994,597 | 2,052,797 | 1,113,346 | 622,415 | |
| loans | |||||||||
| hp & lease commitments | |||||||||
| Accruals and Deferred Income | |||||||||
| other liabilities | |||||||||
| provisions | |||||||||
| total long term liabilities | |||||||||
| total liabilities | 8,107,171 | 54,894,231 | 9,575,324 | 4,518,963 | 2,994,597 | 2,052,797 | 1,113,346 | 622,415 | |
| net assets | 96,355,578 | 126,896,583 | 11,586,648 | -3,646,889 | -2,276,516 | -1,262,832 | -922,038 | -480,418 | 1,000 |
| total shareholders funds | 96,355,578 | 126,896,583 | 11,586,648 | -3,646,889 | -2,276,516 | -1,262,832 | -922,038 | -480,418 | 1,000 |
| Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Dec 2018 | Dec 2017 | May 2017 | May 2016 | May 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Operating Profit | -40,386,533 | 144,338,605 | 19,521,102 | -1,400,935 | -1,009,852 | -340,794 | -441,620 | -481,418 | |
| Depreciation | 4,217,382 | 2,979,964 | 156,598 | 241,030 | 163,631 | 7,577 | 4,513 | 1,783 | |
| Amortisation | |||||||||
| Tax | 10,071,764 | -24,849,860 | -3,640,671 | 50,744 | |||||
| Stock | |||||||||
| Debtors | -75,463,589 | 158,817,126 | 13,332,154 | 277,418 | 26,909 | -36,562 | 68,719 | 100,072 | 1,000 |
| Creditors | -372,443 | 268,102 | 104,341 | -49,012 | 16,297 | 35,877 | 101,577 | ||
| Accruals and Deferred Income | -18,144,627 | 16,338,165 | 3,658,152 | 57,390 | -590 | 37,548 | 25,095 | 9,070 | |
| Deferred Taxes & Provisions | |||||||||
| Cash flow from operations | 31,221,575 | -20,382,695 | 6,631,129 | -1,224,848 | -922,732 | -242,810 | -444,854 | -469,060 | -1,000 |
| Investing Activities | |||||||||
| capital expenditure | |||||||||
| Change in Investments | |||||||||
| cash flow from investments | |||||||||
| Financing Activities | |||||||||
| Bank loans | |||||||||
| Group/Directors Accounts | -28,641,471 | 29,351,250 | 1,130,182 | 4,357,118 | 989,118 | 1,377,095 | 430,205 | 511,138 | |
| Other Short Term Loans | |||||||||
| Long term loans | |||||||||
| Hire Purchase and Lease Commitments | |||||||||
| other long term liabilities | |||||||||
| share issue | |||||||||
| interest | -226,236 | -4,178,810 | -646,894 | -20,182 | -3,832 | ||||
| cash flow from financing | -28,867,707 | 25,172,440 | 483,288 | 2,060,420 | 985,286 | 935,475 | 430,205 | 511,138 | 1,000 |
| cash and cash equivalents | |||||||||
| cash | -48,179 | -6,896,729 | 7,114,342 | 211,055 | -2,817 | -16,456 | -16,482 | 21,316 | |
| overdraft | -962 | 1,935 | -75 | 114 | 2,284 | -558 | -246 | 630 | |
| change in cash | -47,217 | -6,898,664 | 7,114,417 | 210,941 | -5,101 | -15,898 | -16,236 | 20,686 |
randox health london ltd Credit Report and Business Information
Randox Health London Ltd Competitor Analysis
Perform a competitor analysis for randox health london ltd by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other large companies, companies in W1W area or any other competitors across 12 key performance metrics.
randox health london ltd Ownership
RANDOX HEALTH LONDON LTD group structure
Randox Health London Ltd has no subsidiary companies.
Ultimate parent company
RANDOX (IOM) LTD
#0106218
2 parents
RANDOX HEALTH LONDON LTD
09102173
randox health london ltd directors
Randox Health London Ltd currently has 2 directors. The longest serving directors include Dr Stephen Fitzgerald (Oct 2014) and Mr Adrian Doran (Jul 2024).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Stephen Fitzgerald | 74 years | Oct 2014 | - | Director | |
| Mr Adrian Doran | 55 years | Jul 2024 | - | Director |
P&L
June 2023turnover
21.6m
-94%
operating profit
-40.4m
-128%
gross margin
21.1%
-58.68%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2023net assets
96.4m
-0.24%
total assets
104.5m
-0.43%
cash
380.5k
-0.11%
net assets
Total assets minus all liabilities
Similar Companies
randox health london ltd company details
company number
09102173
Type
Private limited with Share Capital
industry
82990 - Other business support service activities n.e.c.
incorporation date
June 2014
age
11
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
June 2023
previous names
randox lifetime health ltd (April 2015)
accountant
-
auditor
KPMG
address
143-149 great portland street, marylebone, london, W1W 6QN
Bank
DANSKE BANK
Legal Advisor
TUGHANS
randox health london ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 5 charges/mortgages relating to randox health london ltd. Currently there are 5 open charges and 0 have been satisfied in the past.
randox health london ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for RANDOX HEALTH LONDON LTD. This can take several minutes, an email will notify you when this has completed.
randox health london ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
